Valuation: SMAIO

Market Cap 48.33M 55.1M 44.76M 41.18M 77.9M 5.27B 79.41M 533M 209M 2.59B 207M 202M 8.94B P/E 2026 *
-24.9x
P/E 2027 * 123x
Enterprise Value 46.23M 52.7M 42.82M 39.39M 74.51M 5.04B 75.96M 510M 200M 2.48B 198M 194M 8.56B EV / Sales 2026 *
3.85x
EV / Sales 2027 * 2.8x
Free-Float
29.17%
Yield 2026 *
-
Yield 2027 * -
1 week-1.38%
Current month+10.57%
1 month+13.79%
3 months+12.89%
6 months+32.00%
Current year+37.28%
1 week 8.3
Extreme 8.3
8.94
1 month 7.44
Extreme 7.44
8.94
Current year 6
Extreme 6
9.1
1 year 5.5
Extreme 5.5
9.1
3 years 2.14
Extreme 2.14
9.1
5 years 1.9
Extreme 1.9
9.1
10 years 1.9
Extreme 1.9
9.1
Manager TitleAgeSince
Chief Executive Officer - 29/12/2008
Director of Finance/CFO - 01/06/2022
Chief Tech/Sci/R&D Officer - 01/07/2020
Director TitleAgeSince
Chairman - 30/07/2021
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.38%+41.82%+263.56% 55.1M
-2.50%-6.44%+44.61%+157.19% 1,054B
-1.92%-5.21%+61.53%+58.44% 621B
-1.43%-3.81%+27.90%+80.10% 438B
-1.12%-3.68%+26.89%+20.58% 325B
-1.73%-3.45%+26.95%+44.09% 281B
-1.95%-13.92%+15.96%+19.76% 262B
-1.45%-2.37%-27.87%-39.87% 219B
-1.49%-3.23%+19.92%+56.62% 195B
-0.97%-4.20%+16.54%+69.23% 163B
Average -1.48%-1.65%+25.43%+72.97% 355.63B
Weighted average by Cap. -1.87%-1.69%+33.28%+77.29%

Financials

2026 *2027 *
Net sales 11.99M 13.67M 11.11M 10.22M 19.33M 1.31B 19.71M 132M 51.92M 643M 51.35M 50.22M 2.22B 16.76M 19.11M 15.52M 14.28M 27.01M 1.83B 27.54M 185M 72.55M 898M 71.75M 70.18M 3.1B
Net income -1.67M -1.91M -1.55M -1.43M -2.7M -183M -2.75M -18.47M -7.25M -89.68M -7.16M -7.01M -310M 278K 317K 257K 237K 448K 30.34M 457K 3.07M 1.2M 14.9M 1.19M 1.16M 51.45M
Net Debt -2.1M -2.39M -1.94M -1.79M -3.38M -229M -3.45M -23.18M -9.09M -113M -8.99M -8.79M -389M -1.4M -1.6M -1.3M -1.19M -2.26M -153M -2.3M -15.45M -6.06M -75.02M -5.99M -5.86M -259M
Logo SMAIO
S.M.A.I.O « Software, Machines and Adaptive Implants in Orthopaedics » is specialized in the design, manufacture and marketing of implantable medical devices for the treatment of spinal pathologies. The company offers the Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. In addition, S.M.A.I.O has developed the Keops and Balance Analyzer 3D surgical planning and patient database management software, and the company also offers training programs. Net sales break down by source of revenue between sales of products (98.9%) and services (1.1%). Net sales are distributed geographically as follows: France (9.8%), Europe (12.2%), the United States (76.2%), Oceania (1%), Middle East and Africa (0.7%) and Canada (0.1%).
Employees
45
Date Price Change Volume
15/07/26 EUR 8.580 0.00% 662
13/07/26 EUR 8.580 +0.94% 106
10/07/26 EUR 8.500 -0.93% 1,388
09/07/26 EUR 8.580 -0.23% 141
08/07/26 EUR 8.600 -1.15% 2,504
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
8.580EUR
Average target price
8.250EUR
Spread / Average Target
-3.85%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALSMA Stock